<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Brue T</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>DAVID syndrome is a rare condition combining anterior pituitary hormone deficiency with common variable immunodeficiency. NFKB2 mutations have recently been identified in patients with ACTH and variable immunodeficiency. A similar mutation was previously found in Nfkb2 in the immunodeficient Lym1 mouse strain, but the effect of the mutation on endocrine function was not evaluated.&lt;h4>Methods&lt;/h4>We ascertained six unrelated DAVID syndrome families. We performed whole exome and traditional Sanger sequencing to search for causal genes. Lym1 mice were examined for endocrine developmental anomalies.&lt;h4>Results&lt;/h4>Mutations in the NFKB2 gene were identified in three of our families through whole exome sequencing, and in a fourth by direct Sanger sequencing. De novo origin of</pubmed_abstract><journal>BMC medical genetics</journal><pagination>139</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4411703</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies.</pubmed_title><pmcid>PMC4411703</pmcid><pubmed_authors>Drouin J</pubmed_authors><pubmed_authors>Van Vliet G</pubmed_authors><pubmed_authors>Patry L</pubmed_authors><pubmed_authors>Schwartzentruber J</pubmed_authors><pubmed_authors>Brue T</pubmed_authors><pubmed_authors>Nassif C</pubmed_authors><pubmed_authors>Takayasu S</pubmed_authors><pubmed_authors>Enjalbert A</pubmed_authors><pubmed_authors>Hasselmann C</pubmed_authors><pubmed_authors>Delemer B</pubmed_authors><pubmed_authors>Souchon PF</pubmed_authors><pubmed_authors>Capo-Chichi JM</pubmed_authors><pubmed_authors>Samuels ME</pubmed_authors><pubmed_authors>Khetchoumian K</pubmed_authors><pubmed_authors>Balsalobre A</pubmed_authors><pubmed_authors>Pagnier A</pubmed_authors><pubmed_authors>Majewski J</pubmed_authors><pubmed_authors>Bensa M</pubmed_authors><pubmed_authors>Papadimitriou DT</pubmed_authors><pubmed_authors>Quentien MH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies.</name><description>&lt;h4>Background&lt;/h4>DAVID syndrome is a rare condition combining anterior pituitary hormone deficiency with common variable immunodeficiency. NFKB2 mutations have recently been identified in patients with ACTH and variable immunodeficiency. A similar mutation was previously found in Nfkb2 in the immunodeficient Lym1 mouse strain, but the effect of the mutation on endocrine function was not evaluated.&lt;h4>Methods&lt;/h4>We ascertained six unrelated DAVID syndrome families. We performed whole exome and traditional Sanger sequencing to search for causal genes. Lym1 mice were examined for endocrine developmental anomalies.&lt;h4>Results&lt;/h4>Mutations in the NFKB2 gene were identified in three of our families through whole exome sequencing, and in a fourth by direct Sanger sequencing. De novo origin of</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Dec</publication><modification>2026-06-08T06:36:31.042Z</modification><creation>2019-03-27T01:50:37Z</creation></dates><accession>S-EPMC4411703</accession><cross_references><pubmed>25524009</pubmed><doi>10.1186/s12881-014-0139-9</doi></cross_references></HashMap>